title: 1,25 Dihydroxyvitamin D3 modulates adenylate cyclase activity of the human breast cancer cell line T47D through increased synthesis of Gs.
authors.affiliation: Laboratoire de pharmacologie, Université Paris VII Hopital St Louis, France.
authors.forename: P
authors.initials: P
authors.lastname: de Cremoux
authors.forename: F
authors.initials: F
authors.lastname: Calvo
authors.forename: G
authors.initials: G
authors.lastname: Lagier
authors.forename: P
authors.initials: P
authors.lastname: Lachat
authors.forename: J P
authors.initials: JP
authors.lastname: Abita
authors.forename: M
authors.initials: M
authors.lastname: Maus
authors.forename: J
authors.initials: J
authors.lastname: Premont
mesh_terms: D000246:Adenosine Diphosphate Ribose / Q000378:metabolism; D000262:Adenylyl Cyclases / Q000032:analysis*; D001943:Breast Neoplasms / Q000201:enzymology*; D002117:Calcitriol / Q000494:pharmacology*; D002772:Cholera Toxin / Q000494:pharmacology; D004789:Enzyme Activation / Q000187:drug effects; D019204:GTP-Binding Proteins / Q000096:biosynthesis*; D006801:Humans; D014407:Tumor Cells, Cultured
chemical_list: D000246:Adenosine Diphosphate Ribose; D002772:Cholera Toxin; D019204:GTP-Binding Proteins; D000262:Adenylyl Cyclases; D002117:Calcitriol